Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Fetterman

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Archives of Internal Medicine|May 30, 2012
Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected womenPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Journal of Virological Methods|June 24, 2008
Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotypingBrandon J LaMere, Renee Howell, Barbara Fetterman, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|November 12, 2015
A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screeningHormuzd A Katki, Li C Cheung, Barbara Fetterman, et al.
Journal of Lower Genital Tract Disease|June 5, 2013
Risk of cervical precancer and cancer in women with cervical intraepithelial neoplasia grade 1 on endocervical curettageEmily Fukuchi, Barbara Fetterman, Nancy Poitras, et al.
Obstetrics and Gynecology|January 23, 2010
Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risksPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Obstetrics and Gynecology|March 21, 2009
Five-year experience of human papillomavirus DNA and Papanicolaou test cotestingPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Gynecologic Oncology|February 1, 2011
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceWalter Kinney, Barbara Fetterman, J Thomas Cox, et al.
Journal of Virological Methods|August 4, 2007
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohortBrandon J LaMere, Janet Kornegay, Barbara Fetterman, et al.
Statistics in Medicine|August 7, 2012
A general binomial regression model to estimate standardized risk differences from binary response dataStephanie A Kovalchik, Ravi Varadhan, Barbara Fetterman, et al.
Gynecologic Oncology|May 8, 2012
Screening history preceding a diagnosis of cervical cancer in women age 65 and olderHelen Dinkelspiel, Barbara Fetterman, Nancy Poitras, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|May 30, 2012
Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected womenPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Journal of Virological Methods|June 24, 2008
Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotypingBrandon J LaMere, Renee Howell, Barbara Fetterman, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|November 12, 2015
A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screeningHormuzd A Katki, Li C Cheung, Barbara Fetterman, et al.
Journal of Lower Genital Tract Disease|June 5, 2013
Risk of cervical precancer and cancer in women with cervical intraepithelial neoplasia grade 1 on endocervical curettageEmily Fukuchi, Barbara Fetterman, Nancy Poitras, et al.
Obstetrics and Gynecology|January 23, 2010
Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risksPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Obstetrics and Gynecology|March 21, 2009
Five-year experience of human papillomavirus DNA and Papanicolaou test cotestingPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Gynecologic Oncology|February 1, 2011
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceWalter Kinney, Barbara Fetterman, J Thomas Cox, et al.
Journal of Virological Methods|August 4, 2007
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohortBrandon J LaMere, Janet Kornegay, Barbara Fetterman, et al.
Statistics in Medicine|August 7, 2012
A general binomial regression model to estimate standardized risk differences from binary response dataStephanie A Kovalchik, Ravi Varadhan, Barbara Fetterman, et al.
Gynecologic Oncology|May 8, 2012
Screening history preceding a diagnosis of cervical cancer in women age 65 and olderHelen Dinkelspiel, Barbara Fetterman, Nancy Poitras, et al.
Pageof 6